Core Insights - AbbVie is actively engaging with the administration regarding drug pricing policies and is optimistic about the productive nature of these discussions [3][4]. Group 1: Company Overview - AbbVie is represented by its entire management team at the Goldman Sachs 46th Annual Global Healthcare Conference [1]. - Robert A. Michael, CEO & Director, emphasizes the importance of addressing affordability and access to medicines while maintaining innovation [4]. Group 2: Industry Environment - The pharmaceutical sector is currently facing uncertainties related to drug pricing policies, particularly following the Most Favored Nation Executive Order [3]. - The administration's engagement with the pharmaceutical industry is seen as a positive development, indicating a willingness to discuss various topics related to drug pricing and access [4].

Eli Lilly (LLY) FY Conference June 10, 2025 08:00 AM ET Speaker0 All right. Great. We're just about at time, so we can get started here. Welcome to good day two of our health care conference. The weather is still holding up. Thank God for that. Very pleased to kick off our morning session this morning with Eli Lilly. We have Lucas Montard, CFO and Mike Zappa, Senior Vice President, Investor Relations. Thank you, Lucas and Mike, for being with us. Happy to be here. Thank you. Great. So I guess to kick off, L ...